VaxGen Vaccine Trial Gets $8 Million in US Government Funding

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

VaxGen Vaccine Trial Gets $8 Million in US Government Funding

Bloomberg News Service (10/19/99)

The Centers for Disease Control and Prevention will provide supplemental support to five trial sites in VaxGen's U.S. Phase III trial of AIDSVAX. CDC will contribute approximately $2 million annually to the selected sites over the next four years. These funds will be distributed to the trial sites directly, not to VaxGen as previously reported. At the trial sites, CDC will supplement current activities with additional research, including behavioral research designed to assess the impact of the trial on the attitudes and behaviors of both trial participants and the community. This information will be critical, not only for the trial, but also for the evaluation of candidate HIV vaccines in the future.

991020
AD991775

Copyright © 1999 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.